Benzinga's Top #PreMarket Gainers
February 26, 2014 at 08:13 AM EST
Anika Therapeutics (NASDAQ: ANIK ) soared 36.21% to $46.95 in the pre-market trading after the company received marketing approval for MONOVISC® from the FDA. TASER International (NASDAQ: TASR ) surged 11.41% to $21.25 in the pre-market session after the company reported upbeat Q4 results. Dyax (NASDAQ: DYAX ) shares